Apical hypertrophic cardiomyopathy: contemporary view on the prevalence, clinical profile, diagnostic and treatmen (review of literature)
https://doi.org/10.24884/1607-4181-2021-28-1-17-22
Abstract
This review presents the last literature data, concerning prevalence, clinical profile, diagnostic and treatment of apical hypertrophic cardiomyopathy (HCM), as less known among «classical» variants of HCM. It is also discussed the rare form of apical HCM — mid-ventricular HCM with apical aneurism formation.
About the Authors
A. A. Streltsova
Almazov National Medical Research Centre
Russian Federation
Competing Interests:
Russian Federation
Streltsova Anna A. - Ultrasound Specialist, Almazov National Medical Research Centre.
Saint Petersburg.
Competing Interests:
Authors declare no conflict of interest.
A. Ya. Gudkova
Almazov National Medical Research Centre; Pavlov University
Russian Federation
Competing Interests:
Russian Federation
Gudkova Aleksandra Ya. - Dr. of Sci. (Med.), Head of the Laboratory of Cardiomyopathies of the Institute of Cardiovascular Diseases of the Scientific and Clinical Research Center, Professor of the Department of Faculty Therapy, Pavlov University; Leading Research Fellow at the Institute of Molecular Biology and Genetics, Almazov National Medical Research Centre.
6-8, L'va Tolstogo str., Saint Petersburg, 197022.
Competing Interests:
Authors declare no conflict of interest.
References
1. Elliott P. M., Anastasakis A., Borger M. A., Borggrefe M., Cecchi F., Charron P., Hagege A. A., Lafont A., Limongelli G., Mahrholdt H., McKenna W. J., Mogensen J., Nihoyannopoulos P., Nistri S., Pieper P. G., Pieske B., Rapezzi C., Rutten F. H., Tillmanns C., Watkins H. ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) // European Heart Journal. 2014;35(39):2733-2779. Doi: 10.1093/eurheartj/ehu284.
2. Liu Q., Li D., Berger A. E., Johns R. A., Gao L. Survival and prognostic factors in hypertrophic cardiomyopathy: a meta-analysis // Scientific Reports. 2017;7(1):11957. Doi: 10.1038/s41598-017-12289-4.
3. Becker R. C., Owens A. P. 3rd, Sadayappan S. Tissue-level inflammation and ventricular remodeling in hypertrophic cardiomyopathy // Journal of Thrombosis and Thrombolysis. 2020;49(2):177-183. Doi: 10.1007/s11239-019-02026-1.
4. Kitaoka H., Doi Y., Casey S. A., Hitomi N., Furuno T., Maron B. J. Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States // American Journal of Cardiology. 2003;92(10):1183-1186. Doi: 10.1016/j.amjcard.2003.07.027.
5. Moon J., Shim C. Y., Ha J. W., Cho I. J., Kang M. K., Yang W. I., Jang Y., Chung N., Cho S. Y. Clinical and echocardiographic predictors of outcomes in patients with apical hypertrophic cardiomyopathy // American Journal of Cardiology. 2011;108(11):1614-1619. Doi: 10.1016/j.amj-card.2011.07.024.
6. Kubo T., Kitaoka H., Okawa M., Hirota T., Hoshikawa E., Hayato K., Yamasaki N., Matsumura Y., Yabe T., Nishinaga M., Takata J., Doi Y. L. Clinical profiles of hypertrophic cardiomyopathy with apical phenotype-comparison of pure-apical form and distal-dominant form // Circulation Journal. 2009 ;73(12): 2330-2336. Doi: 10.1253/circj.cj-09-0438
7. Jan M. F., Todaro M. C., Oreto L., Tajik A. J. Apical hypertrophic cardiomyopathy: Present status // International Journal of Cardiology. 2016;222:745-759. Doi: 10.1016/j.ijcard.2016.07.154.
8. Maron B. J., McKenna W. J., Danielson G. K., Kappenberger L. J., Kuhn H. J., Seidman C. E., Torbicki A. ACC/ ESC Expert Consensus Document on Hypertrophic Cardiomyopathy // Journal of the American College of Cardiology. 2003;42(9):1687-1713. Doi: 10.1016/S0735-1097(03)00941-0.
9. Maron B.J., Ommen S.R., Semsarian C, Spirito P., Ol-ivotto I., Maron M.S. Hypertrophic cardiomyopathy: Present and future, with translation into contemporary cardiovascular medicine // Journal of the American College of Cardiology. 2014;64(1):83-99. DOI:10.1016/j.jacc.2014.05.003.
10. Maron M. S., Finley J. J., Bos J. M., Hauser T. H., Manning W. J., Haas T .S., Lesser J. R., Udelson J. E., Ackerman M. J., Maron B. J. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy // Circulation. 2008;118(15):1541-1549. Doi: 10.1161/CIRCULATIONAHA.108.781401.
11. Cui L., Tse G., Zhao Z., Bazoukis G., Letsas K. P., Korantzopoulos P., Roever L., Li G., Liu T.. Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm: An important subtype of arrhythmogenic cardiomyopathy // Annals of Noninvasive Electrocardiology. 2019; 24(5):e12638. Doi: 10.1111/anec.12638.
12. Cai C., Duan F. J., Yang Y. J., Guo X., Liu Y. L., Liu Y. Q., Yan L. R., Xu Z. M., Zhao S. H., Hua W., Li Y. S., Fan C. M. Comparison of the prevalence, clinical features, and long-term outcomes of midventricular hypertrophy vs apical phenotype in patients with hypertrophic cardiomyopathy // Canadian Journal of Cardiology. 2014;30(4):441-447. Doi: 10.1016/j.cjca.2013.10.005.
13. Tengiz I., Ercan E., Turk U. O. Percutaneous myocardial ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy // International Journal of Cardiovascular Imaging. 2006;22(1):13-18. Doi: 10.1007/s10554-005-5295-8.
14. Tse H. F., Ho H. H. Sudden cardiac death caused by hypertrophic cardiomyopathy associated with midventricular obstruction and apical aneurysm // Heart. 2003;89(2):178. Doi: 10.1136/heart.89.2.178.
15. Towe E. C., Bos J. M., Ommen S. R., Gersh B. J., Ackerman M. J. Genotype-phenotype correlations in apical variant hypertrophic cardiomyopathy // Congenital Heart Disease. 2015;10(3):E139-E145. Doi: 10.1111/chd.12242.
16. Matsubara K., Nakamura T., Kuribayashi T., Azuma A., Nakagawa M. Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy // Journal of the American College of Cardiology. 2003;42(2):288-295. Doi: 10.1016/s0735-1097(03)00576-x.
17. Minami Y., Kajimoto K., Terajima Y., Yashiro B., Okayama D., Haruki S., Nakajima T., Kawashiro N., Kawana M., Hagiwara, N. Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy // Journal of the American College of Cardiology. 2011; 57(23):2346-2355. Doi: 10.1016/j.jacc.2011.02.033.
18. Pivatto Jr.F., Mossmann M., Krepsky A.M., Zago A. Mid-Ventricular Hypertrophic Obstructive Cardiomyopathy // Revista Brasileira de Cardiologia Invasiva. 2014;22(2);180-182. Doi: 10.1590/0104-1843000000030.
19. Cui L., Suo Y., Zhao Y., Li G., Liu T. Mid-Ventricular Obstructive Hypertrophic Cardiomyopathy and Apical Aneurysm Mimicking Acute ST-Elevation Myocardial Infarction // Annals of Noninvasive Electrocardiology. 2016;21(1):98-101. Doi: 10.1111/anec.12284
20. Morner S., Johansson B., Henein M. Arrhythmogenic left ventricular apical aneurysm in hypertrophic cardiomyopathy // International Journal of Cardiology. 2011;151(1):e8-e9. Doi: 10.1016/j.ijcard.2010.02.071
21. Dilaveris P., Aggeli, C., Synetos A., Skiadas, I., Antoniou C.K., Tsiamis E., Tousoulis D. Sustained ventricular tachycardia as a first manifestation of hypertrophic cardiomyopathy with mid-ventricular obstruction and apical aneurysm in an elderly female patient // Annals of Noninvasive Electrocardiology. 2017;22(3):e12422. Doi: 10.1111/anec.12422.
22. Pёrez-Riera A. R., Barbosa-Barros R., de Lucca A. A., Viana M. J., de Abreu L. C. Mid-ventricular Hypertrophic Obstructive Cardiomyopathy with Apical Aneurysm Complicated with Syncope by Sustained Monomorphic Ventricular Tachycardia // Annals of Noninvasive Electrocardiology. 2016;21(6):618-621. Doi: 10.1111/anec.12377.
23. Sato Y., Matsumoto N., Matsuo S., Yoda S., Kunimoto S., Saito S. Mid-ventricular hypertrophic obstructive cardiomyopathy presenting with acute myocardial infarction // Texas Heart Institute Journal. 2007;34(4):475-478.
24. Pacheco Claudio C., Quesada O., Pepine C.J., Noel Bairey Merz C. Why names matter for women: MINOCA/IN-OCA (myocardial infarction/ischemia and no obstructive coronary artery disease) // Clinical Cardiology. 2018;41(2):185-193. Doi: 10.1002/clc.22894.
25. Hypertrophic cardiomyopathy: Clinical recommendations / Russian Society of Cardiology. 2020
26. Hamada M. Left Ventricular Thrombus in Hypertrophic Cardiomyopathy // Internal Medicine. 2019;58(4):465-467. Doi: 10.2169/internalmedicine.
27. Raza M., Chalfoun N., Wissam A., Hashmi H., McNamara R. Hypertrophic cardiomyopathy with a large apical ventricular aneurysm and mural thrombus // Global Cardiology Science and Practice. 2018;(1):9. Doi: 10.21542/gcsp.2018.9.
28. Alfonso F., Frenneaux M. P., McKenna W. J. Clinical sustained uniform ventricular tachycardia in hypertrophic cardiomyopathy: association with left ventricular apical aneurysm // British Heart Journal. 1989;61(2):178-181. Doi: 10.1136/hrt.61.2.178
29. Gao X. J., Kang L. M., Zhang J., Dou K. F., Yuan J. S., Yang Y. J. Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm and sustained ventricular tachycardia: a case report and literature review // China Medical Journal (Engl). 2011;124(11):1754-1757.
30. Seggewiss H., Faber L. Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction // European Journal of Echocardiography. 2000; 1:277-280. Doi: 10.1053/euje.2000.0032.
31. Kunkala M. R., Schaff H. V., Nishimura R. A., Abel M. D., Sorajja P., Dearani J. A., Ommen S. R. Transapical approach to myectomy for midventricular obstruction in hypertrophic cardiomyopathy // The Annals of Thoracic Surgery. 2013;96(2):564-570. Doi: 10.1016/j.athoracsur.2013.04.073.
32. Said S. M., Schaff H. V., Abel M. D., Dearani J. A. Transapical approach for apical myectomy and relief of midventricular obstruction in hypertrophic cardiomyopathy // Journal of Card Surgery. 2012;27(4):443-448. Doi: 10.1111/j.1540-8191.2012.01475.x.
33. Yang Y. J., Fan C. M., Yuan J. Q., Wang S. Y., Song Y. H., Qiao S. B., You S. J., Wang Z. M., Duan F. J., Li Y. S. Effectiveness of alcohol septal ablation versus transaortic extended myectomy in hypertrophic cardiomyopathy with midventricular obstruction // Journal of Interventional Cardiology. 2016;(29):619-627. Doi: 10.1111/joic.12331
34. Nguyen A., Schaff H. V., Nishimura R. A., Dearani J. A., Ommen S. R. Early outcomes of repair of left ventricular apical aneurysms in patients with hypertrophic cardiomyopathy // Circulation. 2017;(136):1979-1981. Doi: 10.1161/CIRCULATIONAHA.117.030593.
35. Sato Y., Matsumoto N., Matsuo S., Yoda S., Tani S., Kasamaki Y., Takayama T., Kunimoto S., Saito S. Mid-ventricular obstructive hypertrophic cardiomyopathy associated with an apical aneurysm: evaluation of possible causes of aneurysm formation // Yonsei Medical Journal. 2007;48(5):879-882. Doi: 10.3349/ymj.2007.48.5.879.
36. Takeda I., Sekine M., Matsushima H., Hosomi N., Nakamura T., Ohtsuki T., Yamawaki T., Matsumoto M. Two cases of cerebral embolism caused by apical thrombi in mid-ventricular obstructive cardiomyopathy // Internal Medicine. 2011;50(9):1059-1060. Doi: 10.2169/internalmedicine.50.5079.
37. Elsheshtawy M. O., Mahmoud A. N., Abdelghany M., Suen I. H., Sadiq A., Shani J. Left ventricular aneurysms in hypertrophic cardiomyopathy with midventricular obstruction: A systematic review of literature // Pacing and Clinical Electrophysiology. 2018;41(7):854-865. Doi: 10.1111/pace.13380.
38. Hughes R. K., Knott K. D., Malcolmson J., Augusto J. B., Mohiddin S. A., Kellman P., Moon J. C., Captur G. Apical Hypertrophic Cardiomyopathy: The Variant Less Known // Journal of the American Heart Association. 2020; 9(5):e015294. Doi: 10.1161/JAHA.119.015294.
Review
For citations:
Streltsova A.A., Gudkova A.Ya. Apical hypertrophic cardiomyopathy: contemporary view on the prevalence, clinical profile, diagnostic and treatmen (review of literature). The Scientific Notes of the Pavlov University. 2021;28(1):17-22. (In Russ.) https://doi.org/10.24884/1607-4181-2021-28-1-17-22
Views:
770
Email this article 